Everglades virus infection in man, 1975. 1980

C H Calisher, and F A Murphy, and J K France, and J S Lazuick, and D J Muth, and F Steck, and H S Lindsey, and S P Bauer, and E E Buff, and N J Schneider

Within 72 hours of visiting the Everglades National Park in south Florida, a 43-year-old man became ill with fever, malaise, myalgia, severe headache, pharyngitis, and enlarged, tender lymph nodes. Everglades (Venezuelan equine encephalomyelitis, subtype II) virus was isolated from a blood sample drawn from the patient five days after onset of symptoms.

UI MeSH Term Description Entries
D008297 Male Males
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D004683 Encephalomyelitis, Equine A group of ALPHAVIRUS INFECTIONS which affect horses and man, transmitted via the bites of mosquitoes. Disorders in this category are endemic to regions of South America and North America. In humans, clinical manifestations vary with the type of infection, and range from a mild influenza-like syndrome to a fulminant encephalitis. (From Joynt, Clinical Neurology, 1996, Ch26, pp8-10) Encephalitis, Equine,Equine Encephalomyelitis Virus Infections,Equine Encephalitis,Equine Encephalomyelitis Viral Infections,Infections, Equine Encephalomyelitis Virus,Equine Encephalomyelitis
D004685 Encephalomyelitis, Venezuelan Equine A form of arboviral encephalitis endemic to Central America and the northern latitudes of South America. The causative organism (ENCEPHALITIS VIRUS, VENEZUELAN EQUINE) is transmitted to humans and horses via the bite of several mosquito species. Human viral infection may be asymptomatic or remain restricted to a mild influenza-like illness. Encephalitis, usually not severe, occurs in a small percentage of cases and may rarely feature SEIZURES and COMA. (From Joynt, Clinical Neurology, 1996, Ch26, pp9-10) Encephalitis, Venezuelan Equine,Encephalomyelitides, Venezuelan Equine,Equine Encephalitis, Venezuelan,Equine Encephalomyelitides, Venezuelan,Venezuelan Equine Encephalitis,Venezuelan Equine Encephalomyelitides,Equine Encephalomyelitis, Venezuelan,Venezuelan Equine Encephalomyelitis
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C H Calisher, and F A Murphy, and J K France, and J S Lazuick, and D J Muth, and F Steck, and H S Lindsey, and S P Bauer, and E E Buff, and N J Schneider
December 2004, Emerging infectious diseases,
C H Calisher, and F A Murphy, and J K France, and J S Lazuick, and D J Muth, and F Steck, and H S Lindsey, and S P Bauer, and E E Buff, and N J Schneider
January 1974, Bulletin de la Societe de pathologie exotique et de ses filiales,
C H Calisher, and F A Murphy, and J K France, and J S Lazuick, and D J Muth, and F Steck, and H S Lindsey, and S P Bauer, and E E Buff, and N J Schneider
July 1964, Transactions of the Royal Society of Tropical Medicine and Hygiene,
C H Calisher, and F A Murphy, and J K France, and J S Lazuick, and D J Muth, and F Steck, and H S Lindsey, and S P Bauer, and E E Buff, and N J Schneider
January 1972, Bulletin de la Societe de pathologie exotique et de ses filiales,
C H Calisher, and F A Murphy, and J K France, and J S Lazuick, and D J Muth, and F Steck, and H S Lindsey, and S P Bauer, and E E Buff, and N J Schneider
May 1960, Annals of the New York Academy of Sciences,
C H Calisher, and F A Murphy, and J K France, and J S Lazuick, and D J Muth, and F Steck, and H S Lindsey, and S P Bauer, and E E Buff, and N J Schneider
December 1994, Agents and actions,
C H Calisher, and F A Murphy, and J K France, and J S Lazuick, and D J Muth, and F Steck, and H S Lindsey, and S P Bauer, and E E Buff, and N J Schneider
June 2019, Emerging infectious diseases,
C H Calisher, and F A Murphy, and J K France, and J S Lazuick, and D J Muth, and F Steck, and H S Lindsey, and S P Bauer, and E E Buff, and N J Schneider
January 1974, Annual review of medicine,
C H Calisher, and F A Murphy, and J K France, and J S Lazuick, and D J Muth, and F Steck, and H S Lindsey, and S P Bauer, and E E Buff, and N J Schneider
June 1983, The British journal of dermatology,
C H Calisher, and F A Murphy, and J K France, and J S Lazuick, and D J Muth, and F Steck, and H S Lindsey, and S P Bauer, and E E Buff, and N J Schneider
December 2006, Emerging infectious diseases,
Copied contents to your clipboard!